Protein Stability Oligonucleotide Stability Flashcards

(27 cards)

1
Q

What is the Drug Development Process defined according to what?

A
  • What the regulatory agencies require e.g. FDA, TGA
  • They all require:
    • Physical and chemical properties (e.g. if we don’t know solubility - can’t formulate with confidence)
    • PK properties (e.g. half life, distribution)
    • Analytical methods
    • Manufacturing methods
    • Animal, human studies
    • Documentation
    • Marketing approval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug Development Process: What are the Important Physical and Chemical Properties?

A
  • Melting point, boiling point
  • pKa
  • Hygroscopicity
  • Solubility
  • Partition coefficient
  • Stability (light, acid/base)
  • Optical activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Protein Structure: What is the Primary Structure?

A
  • Covalent backbone of polypeptide chain and sequence of amino acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Protein Structure: What is the Secondary Structure?

A
  • Regular, recurring arrangement in space of the polypeptide chain along one dimension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Protein Structure: What is the Tertiary Structure?

A
  • Holy polypeptide chain is bent or folded in 3D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Protein Structure: What is the Quaternary Structure?

A
  • How the individual polypeptide chains having two or more chains are arranged in relation to each other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Protein Structures: What does Confirmation refer to?

A
  • More general term to refer to the combined secondary, tertiary and quaternary structure of protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Protein Structures: What does Oligomeric Proteins refer to?

A
  • Proteins with one or more polypeptide chains - there component chains are called subunits or protomers
  • e.g. haemoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What bonds do Protein Structures consist of?

A
  • Electrostatic Interactions
  • Hydrogen bonding
  • Van der Waals forces
  • Hydrophobic interactions
  • Disulphide crosslinks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Conformational Structure may be altered due to?

A
  • pH changes
    • Changing pH can affect stability
    • e.g. pH too high or low in injectable - vein damage or discomfort
  • Ionic strength changes
    • e.g. injectable product - adjust closer to isotonic to avoid stinging
  • Surface active agents
    • SLS - added to optimal concentration and increase stability and solubility
  • Shear stresses
    • Can occur if manufacturer has a tank that needs to pump to another tank that can cause enough shear to cause degradation
  • Adsorption
    • e.g. molecule in solution, not soluble in water - stick to surfaces e.g. glass
  • Disruption of water-protein interactions
    • These interactions can change depending on differences in concentration of the peptide within the solution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are Degradation Pathways?

A
  • Hydrolysis, including deamidation
  • Other deamidation reactions
  • Transpeptidation
  • Racemisation
  • Oxidation
  • Diketopiperazine formation
  • Disulphide exchange
  • Photodecomposition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Native, Functional Protein?

What can happen to this protein in Solution?

A
  • Any protein or peptide that might be in an injectable form or already circulating the body is a native, functional protein
    • It is active
    • Slowly degrading
  • Rate of unfolding and refolding depends on pH, temperature
    • Reversible process, there’s equilibrium constant
    • In equilibrium with Partially or Fully Unfolded Protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens to the Partially or Fully Unfolded Protein?

A
  • Noncovalent changes (Physical attraction in some way, not usually administered with other drugs)
    • Aggregation
      • molecule in solution, over time, slow unfolding and reversible process going on, a portion of the partially or fully unfolded protein may start to aggregate with itself - still remains in solution
      • Not active when in this form
    • Surface adsorption
      • The larger the molecule, the less soluble in water, the more likely the surface adsorption will be
    • Precipitation
      • Can happen because of aggregation - solution becomes cloudy
  • Covalent Changes (irreversible)
    • Deamidation
    • Hydrolysis
    • Oxidation/photodecomposition
    • Racemisation
    • Disulphide exchange
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the important points of Asparaginyl Hydrolysis?

A
  • All peptides are susceptible to hydrolysis
  • Asparaginyl group most reactive
  • Different mechanisms can occur
  • The breakdown products are different and any of those breakdown products could be much less active in the patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can we improve stability of Asparginyl Groups?

What is a problem with this?

A
  • Could look at the amino acid sequence and replace glutamyl with glutamyl residue which can eliminate or reduce the side reaction which can increase the shelf-life
  • However, if they change the sequence, it may change what happens at the receptor - may diminish activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Is Adrenocorticotrophic Hormone soluble in water?

A
  • Freely soluble in water, partly precipitated at pI (4.65-4.8)
    • If we increase pH away from pI = overall negative charge on molecule
    • If we decrease pH away from pI = overall positive charge on molecule and therefore more soluble
17
Q

What are Disulfide Bonds?

A
  • Most common encountered cross-link of proteins
  • The only covalent link synthesised de novo in globular proteins
  • Can be between two portions of a single chain or bridge between two otherwise independent chains
  • Formation from oxidation of two cysteine residues
18
Q

Disulfide bonds: Cross-link formation - half-reaction for oxidation of cysteine to disulphide

Is this reaction reversible?

What does it form?

A
  • It is reversible
  • Form disulphide bridge
19
Q

Disulfide Exchange

What do the rates of forward and backward reactions depend on?

A
  • Rates of forward and backward reactions are pH dependent since the thiolate ion participates
  • Depending on the pKa of the thiols, electrostatic environment, position within folding, ring strain - can influence the rate of disulfide exchange occuring
  • GSH has be used to help stabilise peptides and proteins
20
Q

What is a normal measure of Small Molecule Solubility?

A
  • Excess solid in solvent at appropriate pH, stir it up for 24hrs (if stable), filter, take off the solid, take the filtrate, dilute it out to appropriate amount, then determine the concentration, then allow for the dilution factor, then they can work out solubility
  • This is ok for small molecule but for a peptide or protein, as it gets more and more concentrated, just forms a gluggy mess
21
Q

How to Measure Protein Solubility?

A
  • Different concentrations of PEG 8000 - dissolve in water
  • Add the peptide and protein to the PEG
    • Easier to find a point where cloudiness starts = this is the maximum solubility
  • Can use as little as 10mg of protein
22
Q

Protein Solubility: What can Organic Solvents do?

A
  • Decrease dielectric constant
  • Increase electrostatic attractions
  • Decrease solute solubility
23
Q

Protein Solubility: What can Polyols and Sugars do?

A
  • Can increase solubility
  • Can increase stability at a higher concentration
  • Trial and error at different pH, different concentrations, different excipients - determine what works best for solubility and stability
24
Q

List the processes of Protein Adsorption

A
  • Adsorption to solid surfaces
  • Solid/liquid interface
  • Air/water
  • Oil/water
25
Chelating Agents (e.g. EDTA) - what is the role?
* Can decrease initiators of free-radical oxidation reactions * Heavy metals help to catalyse these healthy metal reactions * Reducing agents can reduce an oxidised drug * Oxidised compounds are more readily oxidised than the agents they are to protect
26
What are Chain Terminators?
* Agents capable of reacting with radicals in solutions to produce a new species, a chain terminator radical, which doesn't re-enter the radical propagation cycle * The new radical may be intrinsically stable or may dimerise to form an inert molecule
27
What are other strategies to help reduce oxidation?
* Adjust pH * Under nitrogen * Low rates of shear * Appropriate containers * Appropriate closures * Prevent exposure to light * Optimum storage temperature